Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

CureVac AG. (7/31/17). "Press Release: The 5th International mRNA Health Conference to Showcase Tremendous Advances in the Development of mRNA Drugs". Tübingen & Berlin.

Region Region Berlin
  Country Germany
Organisations Organisation CureVac AG
  Group CureVac (Group)
  Organisation 2 Moderna Therapeutics Inc.
  Group Moderna (Group)
Products Product International mRNA Health Conference 2017 Berlin
  Product 2 mRNA-based drug
Persons Person Hoerr, Ingmar (CureVac 200601 CEO + co-founder)
  Person 2 Rando, Jason (Tiberend Strategic Advisors 201707 EVP + COO)
     


> Global Thought Leaders Convene to Share Progress in Research and Development of mRNA Products Believed to be the Next Evolution in Human Medicine


> November 1-2, 2017 / Berlin, Germany

> Early-Bird Registration Open


The 5th International mRNA Health Conference, taking place on November 1-2 in Berlin, Germany, is the premier meeting destination for professionals and academia in the field of mRNA drugs. In its fifth year, the conference is returning to Berlin to celebrate the remarkable research, preclinical and clinical progress of the past year. The event will provide participants an opportunity to attend scientific presentations given by the most esteemed experts in the field, secure updates on advances in mRNA technology, and to network with colleagues.

Hundreds of world renowned innovators, scientists, academia and pharmaceutical delegates are expected to attend the conference as mRNA therapeutic technology evolves from scientific concept to medical application. Approximately 25 speakers will present on preclinical and clinical development in the fields of oncology, infectious diseases and molecular therapies as well as mRNA delivery, design and product development. Additionally, a poster session will provide research groups and company representatives the opportunity to showcase their data to attendees.

Ingmar Hoerr, Ph.D., founding member of the International mRNA Health Conference and CEO of CureVac, commented, “The mRNA industry has witnessed a multitude of transformational events over the past twelve months, with multiple programs being pushed through the clinic and companies developing infrastructure to prepare for eventual commercialization efforts. It seems that every year since our colleagues from Moderna, BioNTech and we began hosting this meeting, we grow substantially closer to realizing mRNA as an actual medical application. Academics and industry continue to break new ground in understanding the vast potential of the technology across multiple therapeutic fields. With the conference entering its fifth year, we are delighted to welcome our colleagues in the field to celebrate another successful year of mRNA research and development as we bring our vision closer to realization.”

The 5th International mRNA Health Conference
Date: November 1-2, 2017
Place: Berlin, Germany
Location: Sofitel Berlin Kurfürstendamm, Augsburger Strasse 41, 10789 Berlin, Germany
Website: www.mrna-conference.com

Program: The Conference will provide a comprehensive program around the medical use of Messenger RNA. The Science Committee of the Conference with members from three leading mRNA companies, BioNTech, CureVac and Moderna Therapeutics, is calling for abstracts for a potential talk or poster presentation during the conference – see http://mrna-conference.com/program-speakers/

Registration: Register by September 15th and benefit from early bird prices under http://mrna-conference.com/register/

Contact: organization@mrna-conference.com

***

Media Contacts

Verena Lauterbach, Senior Manager Communications
CureVac AG, Tübingen, Germany
T: +49 (0) 7071 9883 1756
verena.lauterbach@curevac.com

Jason Rando, EVP & COO
Tiberend Strategic Advisors, New York
+1 212 375 2665
jrando@tiberend.com

   
Record changed: 2017-10-20

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for CureVac (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px